Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Page 1
Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort.
Guellec D, Carvajal-Alegria G, Daïen C, Gossec L, Guillemin F, Berenbaum F, Constantin A, Dieude P, Dougados M, Flipo RM, Goupille P, Mariette X, Richez C, Vittecoq O, Combe B, Saraux A. Guellec D, et al. Among authors: saraux a. Clin Exp Rheumatol. 2023 Mar;41(3):649-655. doi: 10.55563/clinexprheumatol/bdcl06. Epub 2022 Jul 21. Clin Exp Rheumatol. 2023. PMID: 35894071 Free article.
OBJECTIVES: To assess, in patients with recent-onset arthritis, whether a self-reported familial occurrence of rheumatoid arthritis (RA) is associated with a clinical presentation of the disease, final diagnosis, long-term outcome and treatment decisions. METHODS: The stud …
OBJECTIVES: To assess, in patients with recent-onset arthritis, whether a self-reported familial occurrence of rheumatoid arthritis (RA) is …
Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study.
Doaré E, Robin F, Racapé H, Le Mélédo G, Orione C, Guggenbuhl P, Goupille P, Gervais E, Dernis E, Bouvard B, Marhadour T, Coiffier G, Saraux A. Doaré E, et al. Among authors: saraux a. Rheumatol Ther. 2021 Sep;8(3):1241-1253. doi: 10.1007/s40744-021-00335-7. Epub 2021 Jul 4. Rheumatol Ther. 2021. PMID: 34218418 Free PMC article.
Patients with CCPD had more side effects. The biotherapy was introduced with a long-term objective, while anti-IL-1 therapies are approved for acute crises only....
Patients with CCPD had more side effects. The biotherapy was introduced with a long-term objective, while anti-IL-1 therapies are app …
Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort.
Combe B, Rincheval N, Berenbaum F, Boumier P, Cantagrel A, Dieude P, Dougados M, Fautrel B, Flipo RM, Goupille P, Mariette X, Saraux A, Schaeverbeke T, Sibilia J, Vittecoq O, Daurès JP. Combe B, et al. Among authors: saraux a. Rheumatology (Oxford). 2021 Nov 3;60(11):5073-5079. doi: 10.1093/rheumatology/keab398. Rheumatology (Oxford). 2021. PMID: 33961011
Positivity for anti-citrullinated peptides antibodies (ACPA) was confirmed as a robust predictor of long-term outcome. CONCLUSIONS: We report a very mild 10-year outcome of a large cohort of patients with early RA diagnosed in the early 2000s, which was much better than re …
Positivity for anti-citrullinated peptides antibodies (ACPA) was confirmed as a robust predictor of long-term outcome. CONCLUSIONS: W …
Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study.
Hilliquin P, Barnetche T, Baillet A, Flipo RM, Lespessailles E, Roux C, Fardellone P, Gilbert-Marceau A, Idier I, Constantin A, Shipley E, Baudens G, Saraux A. Hilliquin P, et al. Among authors: saraux a. Rheumatol Ther. 2021 Mar;8(1):95-108. doi: 10.1007/s40744-020-00253-0. Epub 2020 Nov 20. Rheumatol Ther. 2021. PMID: 33216287 Free PMC article.
INTRODUCTION: Drug retention is particularly relevant to assess long-term treatments. This real-world study mainly aimed to describe 1-year retention rate (RR) of subcutaneously administered tocilizumab (TCZ-SC) in patients with moderate to severe active rheumatoid arthrit …
INTRODUCTION: Drug retention is particularly relevant to assess long-term treatments. This real-world study mainly aimed to describe …
Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA).
Molto A, Gossec L, Poiraudeau S, Claudepierre P, Soubrier M, Fayet F, Wendling D, Gaudin P, Dernis E, Guis S, Pouplin S, Ruyssen-Witrand A, Chales G, Mariette X, Beauvais C, Combe B, Flipo RM, Richette P, Chary-Valckenaere I, Saraux A, Sibilia J, Schaeverbeke T, Dougados M. Molto A, et al. Among authors: saraux a. Rheumatology (Oxford). 2021 Feb 1;60(2):888-895. doi: 10.1093/rheumatology/keaa480. Rheumatology (Oxford). 2021. PMID: 33063096 Clinical Trial.
Despite a lack of statistical significance in the primary outcome (e.g. coping) there was a statistically significant difference in favor of this program for the following variables: change in BASDAI, number and duration of the home exercises in the active group, and physical act …
Despite a lack of statistical significance in the primary outcome (e.g. coping) there was a statistically significant difference in favor of …
Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study.
Saraux A, Combe B, Fagnani F, Cukierman G, Bru I, Joubert JM, Schuller JC, Massol J, Flipo RM. Saraux A, et al. Clin Exp Rheumatol. 2021 Jul-Aug;39(4):781-789. doi: 10.55563/clinexprheumatol/fkmsi2. Epub 2020 Sep 1. Clin Exp Rheumatol. 2021. PMID: 32896261 Free article.
OBJECTIVES: To describe the long-term effectiveness and safety of certolizumab pegol in patients with moderate-to-severe rheumatoid arthritis (RA) in a real-world setting in France. ...Other endpoints included DAS28, clinical disease activity index, health assessment quest …
OBJECTIVES: To describe the long-term effectiveness and safety of certolizumab pegol in patients with moderate-to-severe rheumatoid a …
Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial.
Molto A, Gossec L, Poiraudeau S, Claudepierre P, Soubrier M, Fayet F, Wendling D, Gaudin P, Dernis E, Guis S, Pouplin S, Ruyssen A, Chales G, Mariette X, Beauvais C, Combe B, Flipo RM, Richette P, Chary-Valckenaere I, Saraux A, Sibilia J, Schaeverbeke T, Dougados M. Molto A, et al. Among authors: saraux a. Semin Arthritis Rheum. 2020 Aug;50(4):701-708. doi: 10.1016/j.semarthrit.2020.05.012. Epub 2020 May 27. Semin Arthritis Rheum. 2020. PMID: 32521324 Clinical Trial.
However, the number of patients in agreement with recommendations was significantly higher in the active group for vaccinations (flu vaccination: 28.6% vs. 9.9%, p<0.01; pneumococcal vaccination:40.0% vs. 21.1%,p=0.04), for cancer screening (skin cancer screening: 36.3% vs. 17 …
However, the number of patients in agreement with recommendations was significantly higher in the active group for vaccinations (flu vaccina …
Trajectory analysis combining pain and physical function in individuals with knee and hip osteoarthritis: results from the French KHOALA cohort.
Wieczorek M, Rotonda C, Coste J, Pouchot J, Saraux A, Guillemin F, Rat AC. Wieczorek M, et al. Among authors: saraux a. Rheumatology (Oxford). 2020 Nov 1;59(11):3488-3498. doi: 10.1093/rheumatology/keaa148. Rheumatology (Oxford). 2020. PMID: 32375174
METHODS: We used data from the Knee and Hip Osteoarthritis Long-term Assessment (KHOALA) cohort, a French population-based cohort of 878 patients with symptomatic knee and/or hip OA. ...
METHODS: We used data from the Knee and Hip Osteoarthritis Long-term Assessment (KHOALA) cohort, a French population-based cohort of …
Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.
Gossec L, Berenbaum F, Chauvin P, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Saraux A. Gossec L, et al. Among authors: saraux a. Clin Rheumatol. 2018 Oct;37(10):2649-2657. doi: 10.1007/s10067-018-4172-5. Epub 2018 Jun 12. Clin Rheumatol. 2018. PMID: 29948351 Free PMC article.
The QuAD may facilitate this dialogue, and may also be useful in population studies to standardize the assessment and evolution of beliefs over time. People with long-term inflammatory conditions such as rheumatoid arthritis (RA; inflammation of the joints) and axial spond …
The QuAD may facilitate this dialogue, and may also be useful in population studies to standardize the assessment and evolution of beliefs o …
30 results